{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:40:04Z","timestamp":1738924804273,"version":"3.37.0"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1991,6,1]],"date-time":"1991-06-01T00:00:00Z","timestamp":675734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1991,6]]},"DOI":"10.1007\/bf03029730","type":"journal-article","created":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T05:58:28Z","timestamp":1233381508000},"page":"617-628","source":"Crossref","is-referenced-by-count":8,"title":["The pharmacologic treatment of atrial fibrillation"],"prefix":"10.1007","volume":"5","author":[{"given":"Roberto","family":"Bolognesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03029730_CR1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM198204293061709","volume":"306","author":"A Selzer","year":"1982","unstructured":"Selzer A. Atrial fibrillation revisited.N Engl J Med 1982;306:1044\u20131045.","journal-title":"N Engl J Med"},{"key":"BF03029730_CR2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/01.CIR.31.6.888","volume":"31","author":"LD Ostrander","year":"1965","unstructured":"Ostrander LD Jr., Brandt RL, Kjelsberg MD, Epstein FH. Eelctrocardiographic findings among the adult population of a total natural community. Tecumseh, Michigan.Circulation 1965;31:888\u2013898.","journal-title":"Circulation"},{"key":"BF03029730_CR3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","volume":"36","author":"WB Kannel","year":"1982","unstructured":"Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. The Framingham Study.N Engl J Med 1982;36:1018\u20131022.","journal-title":"N Engl J Med"},{"key":"BF03029730_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0954-6820.1984.tb03763.x","volume":"216","author":"P Petersen","year":"1984","unstructured":"Petersen P, Godtfredsen J. Atrial fibrillation. A review of course and prognosis.Acta Med Scand 1984;216:5\u20139.","journal-title":"Acta Med Scand"},{"key":"BF03029730_CR5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/hrt.36.10.1005","volume":"36","author":"A Campbell","year":"1974","unstructured":"Campbell A, Caird FI, Jackson TFM. Prevalence of abnormalities of electrocardiogram in old people.Br Heart J 1974;36:1005\u20131011.","journal-title":"Br Heart J"},{"key":"BF03029730_CR6","first-page":"148","volume-title":"Atrial fibrillation","author":"HE Kulbertus","year":"1982","unstructured":"Kulbertus HE, De Leval-Rutten F, Bartsch P, Petit JM. Atrial fibrillation in elderly ambulatory patients. In: Kulbertus HE, Olsson SB, Schlepper M, eds.Atrial fibrillation. Molndal, Sweden: AB Hassle, 1982:148\u2013157."},{"key":"BF03029730_CR7","first-page":"231","volume-title":"Atrial fibrillation","author":"RA Silva De","year":"1982","unstructured":"De Silva RA, Lown B. Cardioversion for atrial fibrillation. Indications and complications. In: Kulbertus HE, Olsson SB, Schlepper M, eds.Atrial fibrillation. Molndal, Sweden: AB Hassle, 1982:231\u2013239."},{"key":"BF03029730_CR8","first-page":"143","volume-title":"Disorders of cardiac rhythm. Focus on disopyramide","author":"AM Katz","year":"1986","unstructured":"Katz AM.Disorders of cardiac rhythm. Focus on disopyramide. Auckland: ADIS, 1986:143."},{"key":"BF03029730_CR9","first-page":"589","volume-title":"Cardiac arrhythmias","author":"L Resnekov","year":"1980","unstructured":"Resnekov L. High-energy electrical current in the management of cardiac dysrhythmias. In: Mandel WJ, ed.Cardiac arrhythmias. Philadelphia: J.B. Lippincott, 1980: 589\u2013604."},{"key":"BF03029730_CR10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/0002-9343(64)90021-X","volume":"37","author":"JW Hurst","year":"1964","unstructured":"Hurst JW, Paulk EA Jr., Proctor HD, Schlant RG. Management of patients with atrial fibrillation.Am J Med 1964;37:728\u2013741.","journal-title":"Am J Med"},{"key":"BF03029730_CR11","first-page":"413","volume":"14","author":"D Metz","year":"1990","unstructured":"Metz D, Chapoutot L, Chabert JP, et al. Cibenzoline i.v. versus flecainide i.v. dans la reduction des fibrillations auriculaires spontan\u00e9es d\u2019installation recente.L\u2019Information Cardiologique 1990;14:413\u2013416.","journal-title":"L\u2019Information Cardiologique"},{"key":"BF03029730_CR12","first-page":"731","volume-title":"Heart disease","author":"GT Bigger","year":"1980","unstructured":"Bigger GT. Management of arrhythmias. In: Braunwald E, ed.Heart disease. Philadelphia: W.B. Saunders, 1980:731."},{"key":"BF03029730_CR13","first-page":"285","volume-title":"Atrial fibrillation","author":"L Storstein","year":"1982","unstructured":"Storstein L. Role of digitalis in ventricular rate control in atrial fibrillation. In: Kulbertus HE, Olsson SB, Schlepper M, eds.Atrial fibrillation. Molndal, Sweden: AB Hassle, 1982:285\u2013292."},{"key":"BF03029730_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/hrt.63.3.157","volume":"63","author":"JM Rawles","year":"1990","unstructured":"Rawles JM. What is meant by a \u201ccontrolled\u201d ventricular rate in atrial fibrillation.Br Heart J 1990;63:157\u2013161.","journal-title":"Br Heart J"},{"key":"BF03029730_CR15","volume-title":"Trait\u00e9 clinique des maladies du coeur","author":"J Bouillaud","year":"1835","unstructured":"Bouillaud J.Trait\u00e9 clinique des maladies du coeur. Paris: Bailiiere JB, 1835."},{"key":"BF03029730_CR16","first-page":"167","volume-title":"Cardiac arrhythmias","author":"PVL Curry","year":"1980","unstructured":"Curry PVL, Shenasa M. Atrial arrhythmias: Clinical concepts. In: Mandel JW, ed.Cardiac arrhythmias. Philadelphia: J.B. Lippincott, 1980:167\u2013192."},{"key":"BF03029730_CR17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-3565(25)25965-1","volume":"31","author":"C Mendez","year":"1961","unstructured":"Mendez C, Aceves J, Mendez R. Inhibition of adrenergic cardiac acceleration by cardiac glycosides.J Pharmacol Exp Ther 1961;31:191\u2013198.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF03029730_CR18","first-page":"42","volume":"139","author":"TN James","year":"1963","unstructured":"James TN, Nadeau PA. The chronotropic effect of digitalis studied by direct perfusion of sinus node.J Pharmacol Exp Ther 1963;139:42\u201352.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF03029730_CR19","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0002-9149(82)91251-6","volume":"50","author":"HO Klein","year":"1982","unstructured":"Klein HO, Kaplinsky E. Verapamil and digoxin: Their respective effects on atrial fibrillation and their interaction.Am J Cardiol 1982;50:894\u2013902.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0002-9149(89)90076-3","volume":"63","author":"DM Salerno","year":"1989","unstructured":"Salerno DM. Dias VC, Kleiger RE, et al. for the Diltiazem-Atrial Fibrillation\/Flutter Study Group. Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter.Am J Cardiol 1989; 63:1046\u20131051.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR21","first-page":"134","volume-title":"Atrial fibrillation","author":"J Godtfredsen","year":"1982","unstructured":"Godtfredsen J. Atrial fibrillation: Course and prognosis\u2014a follow-up study of 1212 patients. In: Kulbertus HE, Olsson SB, Schlepper M, eds.Atrial fibrillation. Molndal, Sweden: AB Hassle, 1982:134\u2013145."},{"key":"BF03029730_CR22","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0002-9149(85)90741-6","volume":"55","author":"R. Wohlgelernter D Soufer","year":"1985","unstructured":"Soufer R. Wohlgelernter D, Vita NA, et al. Intact systolic left ventricular function in clinical congestive heart failure.Am J Cardiol 1985;55:1032\u20131036.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR23","first-page":"179","volume-title":"Atrial fibrillation","author":"FW Bar","year":"1982","unstructured":"Bar FW, Brugada P, Wellens HJJ. Atrial fibrillation and pre-excitation. In: Kulbertus HE, Olsson SB, Schlepper M, eds.Atrial fibrillation. Molndal, Sweden: AB Hassle, 1982:179\u2013187."},{"key":"BF03029730_CR24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.50.2.353","volume":"50","author":"A George","year":"1975","unstructured":"George A, Spear JF, Moore EN. The effects of digitalis glycosides on the ventricular fibrillation threshold in innervated and denervated canine hearts.Circulation 1975;50: 353\u2013359.","journal-title":"Circulation"},{"key":"BF03029730_CR25","first-page":"140","volume-title":"Cuore e farmaci","author":"FI Marcus","year":"1987","unstructured":"Marcus FI, Opie LH, Sonnenblick EH. Digitale, simpatico mimetici ed inodilatatori. In: Opie LH, ed.Cuore e farmaci. Milano: CNM, 1987:140\u2013172. (An Italian translation of Opie LH, ed.Drugs for the heart, 2nd expanded ed. Springfield, IL: Grune & Stratton, 1987."},{"key":"BF03029730_CR26","first-page":"158","volume-title":"Atrial fibrillation","author":"P Coumel","year":"1982","unstructured":"Coumel P, Leclercq JF, Attuel P. Paroxysmal atrial fibrillation. In: Kulbertus HE, Olsson SB, Schlepper M, eds.Atrial fibrillation. Molndal, Sweden: AB Hassle, 1982: 158\u2013175."},{"key":"BF03029730_CR27","first-page":"1120","volume":"17","author":"F Bender","year":"1966","unstructured":"Bender F, Kojima N, Reploh HD, Oelmann G. Behandlung tachykarder rhythmusstorungen des herzens durch betarezeptorenblockade des atrioventrikulargewebes.Med Welt 1966;17:1120\u20131123.","journal-title":"Med Welt"},{"key":"BF03029730_CR28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-8703(75)90431-7","volume":"90","author":"MK Heng","year":"1975","unstructured":"Heng MK, Singh BN, Roche AHG, et al. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.Am Heart J 1975;90:487\u2013489.","journal-title":"Am Heart J"},{"key":"BF03029730_CR29","first-page":"35","volume":"3","author":"WS Aronow","year":"1980","unstructured":"Aronow WS, Ferlinz J. Verapamil versus placebo in atrial fibrillation and atrial flutter.Clin Invest Med 1980; 3:35\u201339.","journal-title":"Clin Invest Med"},{"key":"BF03029730_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/j.1552-4604.1985.tb02826.x","volume":"25","author":"HR Ochs","year":"1985","unstructured":"Ochs HR, Anda L, Eichelbaum M, Greenblatt DI. Diltiazem, verapamil and quinidine in patients with chronic atrial fibrillation.J Clin Pharmacol 1985;25:204\u2013209.","journal-title":"J Clin Pharmacol"},{"key":"BF03029730_CR31","first-page":"74","volume-title":"Il punto su: I calcioantagonisti in cardiologia","author":"F Milazzotto","year":"1986","unstructured":"Milazzotto F, Di Marco Tullio G, Uguccioni M. I calcioantagonisti nel trattamento del flutter e della fibrillazione atriale. In: Fazzini PF, L\u2019Abbate A, eds.Il punto su: I calcioantagonisti in cardiologia. Firenze: O.I.C. Medical Press, 1986:74\u201386."},{"key":"BF03029730_CR32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/cpt1979266710","volume":"26","author":"J Dominic","year":"1979","unstructured":"Dominic J, McAllister RG, Kuo CS, et al. Verapamil plasma levels and ventricular rate response in patients with atrial fibrillation and flutter.Clin Pharmacol Ther 1979;26:710\u2013714.","journal-title":"Clin Pharmacol Ther"},{"key":"BF03029730_CR33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/cvr\/5.4.419","volume":"5","author":"L Schamroth","year":"1971","unstructured":"Schamroth L. Immediate effects of intravenous verapamil on atrial fibrillation.Cardiovasc Res 1971;5:419\u2013424.","journal-title":"Cardiovasc Res"},{"key":"BF03029730_CR34","first-page":"72","volume":"19","author":"A Kuruvilla","year":"1977","unstructured":"Kuruvilla A, Subramaniam N, Abraham KA, et al. Acute antiarrhythmic effect of intravenous verapamil in supraventricular tachyarrthmias.Indian J Chest Dis Allied Sci 1977;19:72\u201381.","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"BF03029730_CR35","first-page":"30","volume":"15","author":"VL Doschitsin","year":"1975","unstructured":"Doschitsin VL. Comparative evaluation of new medicamentous agents used in the treatment of cardiac arrhythmia.Kardiologjia 1975;15:30\u201337.","journal-title":"Kardiologjia"},{"key":"BF03029730_CR36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-8703(83)90246-6","volume":"105","author":"R Lang","year":"1981","unstructured":"Lang R, Klein H, Di Segni F, et al. Verapamil improves exercise capacity in chronic atrial fibrillation: A double blind crossover study.Am Heart J 1981;105:820\u2013825.","journal-title":"Am Heart J"},{"issue":"11","key":"BF03029730_CR37","first-page":"28","volume":"30","author":"R Bolognesi","year":"1985","unstructured":"Bolognesi R, Cicogna R, Manca C, et al. Associazione verapamil-chinidina nel trattamento delle fibrillazioni atriali. 46\u00b0 Congresso Nazionale SIC, Roma 1985.Cardiologia 1985;30(Suppl. 11):28.","journal-title":"Cardiologia"},{"issue":"12","key":"BF03029730_CR38","first-page":"111","volume":"32","author":"R Bolognesi","year":"1987","unstructured":"Bolognesi R, Tsialtas D, Vasini P, et al. Effetti del verapamil e della combinazione verapamil-chinidina nel trattamento delle fibrillazioni atriali. 48\u00b0 Congresso Nazionale SIC, Roma 1987.Cardiologia 1987;32(Suppl. 12):111.","journal-title":"Cardiologia"},{"key":"BF03029730_CR39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1056\/NEJM198501173120308","volume":"312","author":"A Maisel","year":"1985","unstructured":"Maisel A, Motulsky HJ, Insel P. Hypotension after quinidine plus verapamil.N Engl J Med 1985;312:167\u2013170.","journal-title":"N Engl J Med"},{"key":"BF03029730_CR40","first-page":"304","volume-title":"Atrial fibrillation","author":"HE Kulbertus","year":"1982","unstructured":"Kulbertus HE, Olsson SB, Schlepper M. Control of ventricular rate in atrial fibrillation: Role of verapamil. Discussion. In: Kulbertus HE, Olsson SB, Schlepper M, eds.Atrial fibrillation. Molndal, Sweden: AB Hassle, 1982: 304\u2013306."},{"key":"BF03029730_CR41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.35.3.413","volume":"35","author":"AL Wit","year":"1974","unstructured":"Wit AL, Cranefield PF. The effects of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant AV nodal tachycardia.Circ Res 1974;35:413\u2013425.","journal-title":"Circ Res"},{"key":"BF03029730_CR42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/01.RES.34.2.184","volume":"34","author":"DP Zipes","year":"1974","unstructured":"Zipes DP, Fischer JC. Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog.Circ Res 1974:34:184\u2013192.","journal-title":"Circ Res"},{"key":"BF03029730_CR43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.CIR.63.5.1035","volume":"63","author":"C Kawai","year":"1981","unstructured":"Kawai C, Konishi T, Matsuyama E, Okazaki H. Comparative effects of the three calcium antagonists diltiazem, verapamil and nifedipine on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.Circulation 1981;63:1035\u20131042.","journal-title":"Circulation"},{"key":"BF03029730_CR44","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/hrt.36.3.256","volume":"36","author":"RAJ Spurrel","year":"1974","unstructured":"Spurrel RAJ, Krikler DM, Sowton E. Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in W.P.W. syndrome.Br Heart J 1974;36:256\u2013264.","journal-title":"Br Heart J"},{"issue":"III","key":"BF03029730_CR45","first-page":"262","volume":"62","author":"H Petri","year":"1980","unstructured":"Petri H, Kafka W, Hall D, Rudolph W. Potential acceleration of the ventricular rate in W.P.W. with atrial fibrillation after verapamil (abstr.).Circulation 1980;62(Suppl. III):262.","journal-title":"Circulation"},{"key":"BF03029730_CR46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/cs0740351","volume":"74","author":"SM Pomfret","year":"1988","unstructured":"Pomfret SM, Beasley CRW, Challenor W, Holgate ST. Relative efficacy of oral verapamil and digoxin alone and in combination in the treatment of patients with chronic atrial fibrillation.Clin Sci 1988;74:351\u2013357.","journal-title":"Clin Sci"},{"key":"BF03029730_CR47","first-page":"294","volume-title":"Atrial fibrillation","author":"H Neuss","year":"1982","unstructured":"Neuss H. Control of ventricular rate in atrial fibrillation: Role of verapamil. In: Kulbertus HE, Olsson SB, Schlepper M, eds.Atrial fibrillation. Molndal, Sweden: AB Hassle, 1982:294\u2013303."},{"key":"BF03029730_CR48","first-page":"551","volume":"69","author":"L Seipel","year":"1980","unstructured":"Seipel L, Breithardt G, Abendroth RR, Wiebringhaus E. Vergleichende klinisch-electrophysiologische Untersuchungen verschiedener Ca-antagonisten.Z Kardiol 1980; 69:551\u2013555.","journal-title":"Z Kardiol"},{"key":"BF03029730_CR49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0735-1097(87)80396-0","volume":"9","author":"JS Steinberg","year":"1987","unstructured":"Steinberg JS, Katz RJ, Bren GB, et al. Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise.J Am Coll Cardiol 1987;9:405\u2013411.","journal-title":"J Am Coll Cardiol"},{"key":"BF03029730_CR50","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0735-1097(84)80365-4","volume":"3","author":"RW Walsh","year":"1984","unstructured":"Walsh RW, Porter CB, Starling MR, O\u2019Rourke RA. Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure.J Am Coll Cardiol 1984;3:1044\u20131050.","journal-title":"J Am Coll Cardiol"},{"key":"BF03029730_CR51","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/0002-9149(87)90862-9","volume":"59","author":"DL Kulick","year":"1987","unstructured":"Kulick DL, Mcintosh N, Campese VM, et al. Central and renal hemodynamic effects of hormonal response to diltiazem in severe congestive heart failure.Am J Cardiol 1987;59:1138\u20131143.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR52","first-page":"431","volume-title":"Tachycardias","author":"A Hamer","year":"1987","unstructured":"Hamer A, Mandel WJ. Digitalis and beta-adrenergic blocking drugs for the treatment of tachycardias. In: Surawicz B, Reddy CP, Prystowsky EN, eds.Tachycardias. Boston: Martinus Nijhoff, 1987:431\u2013459."},{"issue":"A","key":"BF03029730_CR53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/8.suppl_A.41","volume":"8","author":"PH Coumel","year":"1987","unstructured":"Coumel PH, Leclercq JF, Escoubet B. Beta blockers: Use for arrhythmias.Eur Heart J 1987;8(Suppl. A):41\u201352.","journal-title":"Eur Heart J"},{"key":"BF03029730_CR54","first-page":"356","volume":"10","author":"R Bolognesi","year":"1980","unstructured":"Bolognesi R, Bruno G, Burani G, et al. L\u2019azione antiaritmica del metoprololo.G Ital Cardiol 1980; 10:356\u2013358.","journal-title":"G Ital Cardiol"},{"key":"BF03029730_CR55","first-page":"721","volume":"34","author":"R Bolognesi","year":"1986","unstructured":"Bolognesi R, Perrone A, Bigoli M, et al. Effetti del metoprololo e.v. nel trattamento delle tachiaritmie sopraventricolari.Minerva Cardioangiol 1986;34:721\u2013724.","journal-title":"Minerva Cardioangiol"},{"key":"BF03029730_CR56","first-page":"367","volume":"12","author":"JF Leclercq","year":"1981","unstructured":"Leclercq JF, Rosengarten MD, Kural S, Attuel P, Coumel P. Effects of beta-blocker\u2019s intrinsic sympathetic activity on S-A and A-V nodes in man.Eur J Cardiol 1981;12: 367\u2013375.","journal-title":"Eur J Cardiol"},{"key":"BF03029730_CR57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/978-94-009-6781-6_28","volume-title":"Frontiers of cardiac electrophysiology","author":"PH Coumel","year":"1983","unstructured":"Coumel PH, Leclercq JF. Role of the autonomic nervous system in the genesis of clinical arrhythmias. In: Rosenbaum MB, Elizari MV, eds.Frontiers of cardiac electrophysiology. Boston: Martinus Nijoff, 1983:552\u2013581."},{"key":"BF03029730_CR58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/cs0760229","volume":"76","author":"KS Channer","year":"1989","unstructured":"Channer KS, James M. Pindolol, not verapamil, in combination with digoxin is the treatment of choice in chronic atrial fibrillation.Clin Sci 1989;76:229\u2013230.","journal-title":"Clin Sci"},{"key":"BF03029730_CR59","doi-asserted-by":"crossref","first-page":"33F","DOI":"10.1016\/0002-9149(85)90914-2","volume":"56","author":"J Morganroth","year":"1985","unstructured":"Morganroth J, Horowitz LN, Anderson J. Turlapaty P, and the Esmolol Research Group. Comparative efficacy and tolerance of esmolol to propranolol for control of supraventricular tachyarrhythmias.Am J Cardiol 1985;56:33F-39F.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0002-8703(86)90551-X","volume":"111","author":"S Anderson","year":"1986","unstructured":"The Esmolol Vs. Placebo Multicenter Study Group: Anderson S, Blanski L, Byrd RC, et al. Comparison of the efficacy and safety of esmolol, a short acting beta-blocker, with placebo in the treatment of supraventricular tachyarrhythmias.Am Heart J 1986;111:42\u201348.","journal-title":"Am Heart J"},{"key":"BF03029730_CR61","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9149(89)90141-0","volume":"63","author":"EV Platia","year":"1989","unstructured":"Platia EV, Michelson EL, Porterfield JK, Das G. Esmolol versus verapamil in the acute treatment of atrial fibrillation and flutter.Am J Cardiol 1989;63:925\u2013929.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR62","first-page":"77","volume-title":"Antiarrhythmic agents","author":"AJ Moss","year":"1973","unstructured":"Moss AJ, Patton RD. Antiarrhythmic agents. Springfield, IL: Charles C. Thomas, 1973:77\u201379."},{"key":"BF03029730_CR63","first-page":"550","volume-title":"Cardiac arrhythmias","author":"BH Singh","year":"1980","unstructured":"Singh BH, Mandel WJ. Antiarrhythmic drugs: Basic concepts of their actions, pharmacokinetic characteristics and clinical applications. In: Mandel WJ, ed.Cardiac arrhythmias. Philadelphia: J.B. Lippincott, 1980:550\u2013588."},{"key":"BF03029730_CR64","first-page":"87","volume-title":"Progress in cardiology 15","author":"DE Haines","year":"1987","unstructured":"Haines DE, Di Marco JP. Use of new and investigational drugs in treating cardiac arrhythmias. In: Yu PN, Goodwin JF, eds.Progress in cardiology 15. Philadelphia: Lea & Febiger, 1987:87\u2013111."},{"key":"BF03029730_CR65","first-page":"137","volume-title":"Amiodarone","author":"L Harris","year":"1986","unstructured":"Harris L, Michat L. Clinical efficacy. Arrhythmias. In: Harris L, Roncucci R, eds.Amiodarone. Paris: MEDSI, 1986:137\u2013161."},{"key":"BF03029730_CR66","first-page":"119","volume-title":"The cardiac arrhythmias","author":"R Slam\u00e0","year":"1979","unstructured":"Slam\u00e0 R, Coumel P, Leclercq JF. Frontiers of the tachycardia-bradycardia syndrome. The Arrhythmia Working Group of the French Cardiac Society, ed.The cardiac arrhythmias. Paris: Corbiere RMDP-Roussel-UCLAF, 1979:119\u2013126."},{"key":"BF03029730_CR67","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0954-6820.1971.tb07436.x","volume":"190","author":"A Redfors","year":"1971","unstructured":"Redfors A. The effect of different digoxin doses on subjective symptoms and physical working capacity in patients with atrial fibrillation.Acta Med Scand 1971;190:307\u2013320.","journal-title":"Acta Med Scand"},{"key":"BF03029730_CR68","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0002-9149(89)90265-8","volume":"63","author":"AS Manolis","year":"1989","unstructured":"Manolis AS, Salem DN, Estes NAM. Electrophysiologic effects, efficacy and tolerance of class IC antiarrhythmic agents in Wolff-Parkinson-White syndrome.Am J Cardiol 1989;63:746\u2013750.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR69","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","volume":"28","author":"PA Wolf","year":"1978","unstructured":"Wolf PA, Dawber TR, Thomas HET, Kannel WB. Epidemiologie assessment of chronic atrial fibrillation and risk of stroke: The Framingham study.Neurology 1978;28:973\u2013977.","journal-title":"Neurology"},{"key":"BF03029730_CR70","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-106-4-503","volume":"106","author":"RH Falk","year":"1987","unstructured":"Falk RH, Knowlton AA, Bernard SA, et al. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm.Ann Intern Med 1987;106:503\u2013506.","journal-title":"Ann Intern Med"},{"key":"BF03029730_CR71","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/0002-9149(79)90456-9","volume":"44","author":"D David","year":"1979","unstructured":"David D, Di Segni ED, Klein HO, Kaplinsky E. Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: Beneficial effect of an added \u03b2- adrenergic blocking agent.Am J Cardiol 1979:44:1378\u20131382.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR72","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/hrt.44.5.589","volume":"44","author":"SW Halpern","year":"1980","unstructured":"Halpern SW, Ellrodt G, Singh BN, Mandel WJ. Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size.Br Heart J 1980;44:589\u2013595.","journal-title":"Br Heart J"},{"key":"BF03029730_CR73","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0002-9149(86)90964-1","volume":"57","author":"RL Gold","year":"1986","unstructured":"Gold RL, Haffajee CI, Charos K, et al. Amiodarone for refractory atrial fibrillation.Am J Cardiol 1986;57:124\u2013127.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR74","first-page":"173","volume":"34","author":"R Bolognesi","year":"1989","unstructured":"Bolognesi R, Tsialtas D, Manca C, Visioli O. Effetti della flecainide nel trattamento delle fibrillazioni atriali parossistiche o di r\u00e9cente origine.Cardiologia 1989;34:173\u2013176.","journal-title":"Cardiologia"},{"key":"BF03029730_CR75","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.CIR.15.4.603","volume":"15","author":"A Picke","year":"1957","unstructured":"Picke A. Digitalis and electrocardiogram.Circulation 1957;15:603\u2013608.","journal-title":"Circulation"},{"key":"BF03029730_CR76","first-page":"78","volume-title":"Essentials of cardiac arrhythimas","author":"S Bellet","year":"1972","unstructured":"Bellet S. Essentials of cardiac arrhythimas. Philadelphia: W.B. Saunders, 1972:78."},{"key":"BF03029730_CR77","first-page":"665","volume-title":"The heart","author":"JW Hurst","year":"1978","unstructured":"Hurst JW.The heart, 4th ed. New York: McGraw-Hill, 1978:665.","edition":"4th ed"},{"key":"BF03029730_CR78","first-page":"1056","volume-title":"Harrison\u2019s principles of internal medicine","author":"BE Sobel","year":"1980","unstructured":"Sobel BE, Braunwald E. Cardiac arrhythmias. In: Isselbacher KJ, Adams RD, Braunwald E, et al., eds.Harrison\u2019s principles of internal medicine, 9th ed. New York: McGraw-Hill, 1980:1056.","edition":"9th ed."},{"key":"BF03029730_CR79","first-page":"362","volume-title":"Disease of the heart","author":"C Friedberg","year":"1966","unstructured":"Friedberg C.Disease of the heart. Philadelphia: W.B. Saunders, 1966:362."},{"key":"BF03029730_CR80","first-page":"62","volume-title":"The disorders of cardiac rhythm","author":"L Schamroth","year":"1971","unstructured":"Schamroth L.The disorders of cardiac rhythm. Oxford: Blackwell Scientific Publications, 1971:62."},{"key":"BF03029730_CR81","first-page":"693","volume-title":"Clinical heart disease","author":"S Oram","year":"1971","unstructured":"Oram S.Clinical heart disease. London: William Heinemann Medical Books, 1971:693."},{"key":"BF03029730_CR82","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-662-11292-2_62","volume-title":"Cardiac glycosides 1785\u20131985","author":"G Steinbeck","year":"1986","unstructured":"Steinbeck G, Doliwa R, Bach P. Cardiac glycosides for paroxysmal atrial fibrillation? In: Erdmann E. Greeff K, Skou JC, eds.Cardiac glycosides 1785\u20131985. New York: Springer-Verlag, Steinkopff:Verlag Darmstadt, 1986:471\u2013475."},{"key":"BF03029730_CR83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00625797","volume":"17","author":"T Jogenstrand","year":"1980","unstructured":"Jogenstrand T. Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: Influence of atrial rhythm.Eur Clin Pharmacol 1980; 17:243\u2013250.","journal-title":"Eur Clin Pharmacol"},{"key":"BF03029730_CR84","first-page":"233","volume":"6","author":"R Bolognesi","year":"1980","unstructured":"Bolognesi R, Effendy FN, Astorri E, Dei Cas L. Effect of gitoformate on disorders of cardiac excitation and conduction.Drugs Exptl Clin Res 1980;6:233\u2013241.","journal-title":"Drugs Exptl Clin Res"},{"key":"BF03029730_CR85","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0002-8703(83)90517-3","volume":"105","author":"P Weiner","year":"1983","unstructured":"Weiner P, Bassan MM, Jarchovsky J, et al. Clinical course of acute atrial fibrillation treated with rapid digitalization.Am Heart J 1983;105:223\u2013227.","journal-title":"Am Heart J"},{"key":"BF03029730_CR86","first-page":"455","volume-title":"Le nuove frontiere delle aritmie","author":"T Lanzetta","year":"1984","unstructured":"Lanzetta T, Svetoni N, Iappelli R, et al. Trattamento e profilassi delle aritmie ipercinetiche sopraventricolari con associazione digitale e chinidina alla luce dei livelli plasmatici dei 2 farmaci. In: Furlanello F, Bettini R, Dal Forno P, et al., eds.Le nuove frontiere delle aritmie. Padova: Piccin, 1984:455\u2013465."},{"key":"BF03029730_CR87","first-page":"226","volume-title":"Cagliari 1965","author":"G Botti","year":"1965","unstructured":"Botti G, Visioli O, Bianchi C. Farmacologia clinica dei farmaci antiaritmici e terapia medica delle aritmie. In: Atti del 26\u00b0 Congresso della Societ\u00e0 Italiana di Cardiologia. Cagliari 1965. Roma: Il Pensiero Scientifico editore 1965: Vol. II, 226\u2013266."},{"key":"BF03029730_CR88","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.CIR.67.1.88","volume":"67","author":"A Betriu","year":"1983","unstructured":"Betriu A, Chaitman BR, Bourassa MG, et al. Beneficial effect of intravenous dilitazem in the acute management of paroxysmal supraventricular tachyarrhythmias.Circulation 1983;67:88\u201394.","journal-title":"Circulation"},{"key":"BF03029730_CR89","first-page":"342","volume-title":"Calcium antagonist in cardiovascular therapy. Experience with verapamil","author":"F. Michelucci A Franchi","year":"1981","unstructured":"Franchi F. Michelucci A, Padeletti L. Distribution of right atrial refractoriness in clinical conditions with intermittent atrial tachyarrhythmias: Effect of acute administration of verapamil. In: Zanchetti A, Krikler DM, eds.Calcium antagonist in cardiovascular therapy. Experience with verapamil. Amsterdam: Excerpta Medica, 1981:342\u2013345."},{"key":"BF03029730_CR90","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9149(88)90967-8","volume":"62","author":"M Shenasa","year":"1988","unstructured":"Shenasa M, Kus T. Fromer M, et al. Effect of intravenous and oral calcium antagonists (dilitiazem and verapamil) on sustenance of atrial fibrillation;Am J Cardiol 1988;62: 403\u2013407.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0002-8703(67)90274-8","volume":"74","author":"S Stern","year":"1967","unstructured":"Stern S. Conversion of chronic atrial fibrillation to sinus rhythm with combined propranolol and quinidine treatment.Am Heart J 1967;74:170\u2013172.","journal-title":"Am Heart J"},{"key":"BF03029730_CR92","first-page":"163","volume":"3","author":"M Bekes","year":"1970","unstructured":"Bekes M, Majkay G, Maklari E, Torok E. Combined application of quinidine and propranolol for the restoration and maintenance of sinus rhythm in supraventricular arrhythmias.Int J Clin Pharmacol 1970;3:163\u2013166.","journal-title":"Int J Clin Pharmacol"},{"key":"BF03029730_CR93","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0002-8703(68)90335-9","volume":"75","author":"O Visioli","year":"1968","unstructured":"Visioli O, Bertaccini G. Combined propranolol and quinidine treatment in cardiac arrhythmias.Am Heart J 1968;75:719.","journal-title":"Am Heart J"},{"key":"BF03029730_CR94","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/hrt.34.9.911","volume":"34","author":"GF Levi","year":"1972","unstructured":"Levi GF, Proto C. Combined treatment of atrial fibrillation with quinidine and beta-blockers.Br Heart J 1972;34: 911\u2013914.","journal-title":"Br Heart J"},{"key":"BF03029730_CR95","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0022-3565(25)32856-9","volume":"219","author":"DH Iansmith","year":"1981","unstructured":"Iansmith DH, Bandura JP, Nash CB. A microelectrophysiological analysis of the pharmacodynamic basis for quinidine-propranolol antiarrhythmic potentiation.J Pharmacol Exp Ther 1981;219:651\u2013658.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF03029730_CR96","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0002-8703(69)90011-8","volume":"78","author":"O Visioli","year":"1969","unstructured":"Visioli O, Botti G, Tagliavini S, et al. Effects of interaction of quinidine and beta-blocking agents on some cardiodynamic and haemodynamic parameters of normal individual.Am Heart J 1969;78:217\u2013228.","journal-title":"Am Heart J"},{"key":"BF03029730_CR97","first-page":"121","volume-title":"Disorders of cardiac rhythm. Focus on disopyramide","author":"J Carlier","year":"1986","unstructured":"Carlier J. Disopyramide in the treatment of supraventricular arrhythmias. In: Kats AM, eds.Disorders of cardiac rhythm. Focus on disopyramide. Auckland: ADIS, 1986: 121\u2013148."},{"key":"BF03029730_CR98","doi-asserted-by":"crossref","first-page":"60D","DOI":"10.1016\/S0002-9149(84)80288-X","volume":"54","author":"P Coumel","year":"1984","unstructured":"Coumel P, Leclercq JF, Assayag P. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.Am J Cardiol 1984;54:60D-66D.","journal-title":"Am J Cardiol"},{"issue":"A","key":"BF03029730_CR99","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/eurheartj\/8.suppl_A.27","volume":"8","author":"M Schlepper","year":"1987","unstructured":"Schlepper M. Propafenone, a review of its profile.Eur Heart J 1987;8(Suppl. A):27\u201332.","journal-title":"Eur Heart J"},{"key":"BF03029730_CR100","doi-asserted-by":"crossref","first-page":"ID","DOI":"10.1016\/0002-9149(88)90511-5","volume":"62","author":"JL Anderson","year":"1988","unstructured":"Anderson JL, Pritchett EL. International symposium on supraventricular arrhythmias: Focus on flecainide.Am J Cardiol 1988;62:ID-67D.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR101","first-page":"137","volume":"III","author":"F. Bilancini A Capestro","year":"1988","unstructured":"Capestro F. Bilancini A, Curzi G, et al. Intravenous flecainide for conversion of atrial fibrillation to sinus rhythm.New Trends Arrhyth 1988;III\/IV:137\u2013140.","journal-title":"New Trends Arrhyth"},{"key":"BF03029730_CR102","first-page":"123","volume":"9","author":"R Bolognesi","year":"1990","unstructured":"Bolognesi R, Tsialtas D, Straneo U, et al. La flecainide nel trattamento delle fibrillazioni atriali parossistiche o di recente insorgenza.Clin Ter Cardiovasc 1990;9:123\u2013127.","journal-title":"Clin Ter Cardiovasc"},{"key":"BF03029730_CR103","first-page":"38D","volume":"62","author":"JJ Goy","year":"1988","unstructured":"Goy JJ, Kaufmann U, Kappenberger L, Sigwart V. Restoration of normal sinus rhythm in patients with atrial fibrillation.Am J Cardiol 1988;62:38D-40D.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR104","doi-asserted-by":"crossref","first-page":"62D","DOI":"10.1016\/0002-9149(88)90511-5","volume":"62","author":"JL Anderson","year":"1988","unstructured":"Anderson JL, Jolivette DM, Fredell PA. Summary of efficacy and safety for flecainide for supraventricular arrhythmias.Am J Cardiol 1988;62:62D-66D.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR105","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/0002-9149(89)90078-7","volume":"63","author":"SS Wafa","year":"1989","unstructured":"Wafa SS, Ward DE, Parker J, Camm J. Efficacy of flecainide acetate for atrial arrhythmias following coronary artery bypass grafting.Am J Cardiol 1989;63:1058\u20131064.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR106","doi-asserted-by":"crossref","first-page":"35D","DOI":"10.1016\/0002-9149(88)90501-2","volume":"62","author":"F Chouty","year":"1988","unstructured":"Chouty F, Coumel P. Oral flecainide use in the treatment of atrial fibrillation.Am J Cardiol 1988;62:35D-37D.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR107","first-page":"327","volume":"35","author":"F Chouty","year":"1986","unstructured":"Chouty F, Leclercq JF, Coumel P. Interet de la flecainide dans les troubles du rhythme supraventriculaire.Ann Cardiol Angeiol 1986;35:327\u2013331.","journal-title":"Ann Cardiol Angeiol"},{"key":"BF03029730_CR108","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/oxfordjournals.eurheartj.a062553","volume":"9","author":"HJGM Crijns","year":"1988","unstructured":"Crijns HJGM, van Wijk LM, van Gilst WH, et al. Acute conversion of atrial fibrillation to sinus rhythm: Clinical efficacy of flecainide acetate. Comparison of two regimens.Eur Heart J 1988;9:634\u2013638.","journal-title":"Eur Heart J"},{"key":"BF03029730_CR109","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"CAST Investigators","year":"1989","unstructured":"CAST Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.N Engl J Med 1989;321:406\u2013413.","journal-title":"N Engl J Med"},{"key":"BF03029730_CR110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/oxfordjournals.eurheartj.a059670","volume":"11","author":"I Sihm","year":"1990","unstructured":"Sihm I, Hansen FA, Rasmussen J, et al. Flecainide acetate in atrial flutter and fibrillation. The arrhythmogenic effects.Eur Heart J 1990;11:145\u2013148.","journal-title":"Eur Heart J"},{"key":"BF03029730_CR111","doi-asserted-by":"crossref","first-page":"67D","DOI":"10.1016\/0002-9149(88)90511-5","volume":"62","author":"J Anderson","year":"1988","unstructured":"Anderson J, Neuss H, Chouty F, et al. Discussion. The role of flecainide in the future management of supraventricular arrhythmias.Am J Cardiol 1988;62:67D.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR112","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0002-9149(90)90851-Q","volume":"66","author":"FI Marcus","year":"1990","unstructured":"Marcus FI. The hazards of using type I C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation.Am J Cardiol 1990;66:366\u2013367.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR113","first-page":"473","volume":"76","author":"JF Leclercq","year":"1983","unstructured":"Leclercq JF, Coumel P. La flecainide, un nouvel antiarythmique.Arch Mal Coeur 1983;76:473\u2013482.","journal-title":"Arch Mal Coeur"},{"key":"BF03029730_CR114","first-page":"342","volume-title":"Cardiac arrhythmias","author":"HJJ Wellens","year":"1980","unstructured":"Wellens HJJ, Farr\u00e9 J, Bar FWHM. The Wolf Parkinson White syndrome. In: Mandel WJ, ed.Cardiac arrhythmias. Philadelphia: J.B. Lippincott, 1980:342\u2013365."},{"key":"BF03029730_CR115","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0002-8703(88)90032-4","volume":"115","author":"HJG Crijns","year":"1988","unstructured":"Crijns HJG, Den Heijer P, Van Wijk CM, Lie KI. Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome.Am Heart J 1988;115:1317\u20131321.","journal-title":"Am Heart J"},{"key":"BF03029730_CR116","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/clc.4960080603","volume":"8","author":"LJ Kappenberger","year":"1985","unstructured":"Kappenberger LJ, Fromer MA, Shenasa M, Gloor HO. Evaluation of flecainide acetate in rapid atrial fibrillation complicating Wolff-Parkinson-White syndrome.Clin Cardiol 1985;8:321\u2013327.","journal-title":"Clin Cardiol"},{"key":"BF03029730_CR117","first-page":"151","volume-title":"The cardiac arrhythmias","author":"R Slam\u00e0","year":"1979","unstructured":"Slam\u00e0 R, Mott\u00e8 G, Groulleau R. Paroxysmal atrioventricular blocks. In: Arrhythmia Working Group of the French Cardiac Society, ed.The cardiac arrhythmias. Paris: Corbiere R.M.D.P. Roussel-UCLAF, 1979:151\u2013163."},{"key":"BF03029730_CR118","first-page":"261","volume-title":"Cardiac arrhythmias: Electrophysiologic, techniques and management","author":"EW Grogan","year":"1985","unstructured":"Grogan EW, Waxman FL. Management of supraventricular arrhythmias. In: Dreifus L, ed.Cardiac arrhythmias: Electrophysiologic, techniques and management. Philadelphia: F.A. Davis, 1985:261\u2013278."},{"issue":"1","key":"BF03029730_CR119","first-page":"490","volume":"4","author":"G Cramer","year":"1968","unstructured":"Cramer G. Early and late results of conversion of atrial fibrillation with quinidine.Acta Med Scand 1968;4(Suppl. 1):490\u2013495.","journal-title":"Acta Med Scand"},{"key":"BF03029730_CR120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/j.1552-4604.1985.tb02826.x","volume":"25","author":"HR Ochs","year":"1985","unstructured":"Ochs HR, Anda L, Eichelbaum M, Greenblatt DJ. Diltiazem, verapamil and quinidine in patients with chronic atrial fibrillation.J Clin Pharmacol 1985;25:204\u2013209.","journal-title":"J Clin Pharmacol"},{"key":"BF03029730_CR121","first-page":"1670","volume":"21","author":"GG Belz","year":"1970","unstructured":"Belz GG, Olesch K. Schmidt-Voigt J. Die behandlung des chronischer vorhofflimmerns mit einer kombination von chinidin und verapamil.Med Welt 1970;21:1670\u20131672.","journal-title":"Med Welt"},{"key":"BF03029730_CR122","first-page":"272","volume":"103","author":"F Bender","year":"1973","unstructured":"Bender F. Die moderne arzneitherapie der rhythmusstorungen.Schweiz Med Wschr 1973;103:272\u2013277.","journal-title":"Schweiz Med Wschr"},{"key":"BF03029730_CR123","first-page":"196","volume":"75","author":"H Gulker","year":"1980","unstructured":"Gulker H, Bramann HU, Brisse B, Kuhs H. Kombinierte behandlung chronischer vorhof-rhythmusstorungen mit chinidin-verapamil.Med Klin 1980;75:196\u2013198.","journal-title":"Med Klin"},{"key":"BF03029730_CR124","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1055\/s-2008-1070140","volume":"107","author":"OA Beck","year":"1982","unstructured":"Beck OA, G\u00fcnther R, Hochrein H. Konversionbehandlung von chronischem vorhoff\u00fcmmern und-flattern mit disopyramid und einer verapamil-chinidin-kombination.Dtsch Med Wschr 1982;107:1419\u20131423.","journal-title":"Dtsch Med Wschr"},{"key":"BF03029730_CR125","first-page":"1569","volume":"99","author":"A Kleinebenne","year":"1981","unstructured":"Kleinebenne A, Mannebach H, Gleichmann U. Chinidin und verapamil kombinationstherapie zur behandlung von vorhof-rhythmusstorungen.Fortschr Med 1981;99:1569\u20131575.","journal-title":"Fortschr Med"},{"key":"BF03029730_CR126","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.64.3.437","volume":"64","author":"SE Epstein","year":"1981","unstructured":"Epstein SE, Rosing DA. Verapamil: Its potential for causing serious complications in patients with hypertrophic cardiomyopathy.Circulation 1981;64:437\u2013441.","journal-title":"Circulation"},{"key":"BF03029730_CR127","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9149(83)90121-2","volume":"52","author":"SJ Yeh","year":"1983","unstructured":"Yeh SJ, Kou HC, Lin PC, et al. Effects of oral diltiazem in paroxysmal supraventricular tachycardia.Am J Cardiol 1983:52:271\u2013278.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0033-0620(82)90025-1","volume":"25","author":"JV Talano","year":"1982","unstructured":"Talano JV, Tommaso C. Slow channel calcium antagonists in the treatment of supraventricular tachycardia.Prog Cardiovasc Dis 1982;25:141\u2013156.","journal-title":"Prog Cardiovasc Dis"},{"key":"BF03029730_CR129","unstructured":"Komajda M, et al. Long term experience of amidarone in arrhythmias and ischaemic heart disease. In: 8th Asian-Pacific Congress Cardiol. Nov. 27\u2013December 1, 1983:1\u2013250."},{"key":"BF03029730_CR130","first-page":"427","volume":"22","author":"JP Fauchier","year":"1973","unstructured":"Fauchier JP. Etude clinique des effets anti-arhythmiques ventriculaires de l\u2019amiodarone (orale et injectable).Ann Cardiol Angiol 1973;22:427\u2013435.","journal-title":"Ann Cardiol Angiol"},{"key":"BF03029730_CR131","first-page":"93","volume":"122","author":"D Tsialtas","year":"1987","unstructured":"Tsialtas D, Ghiringhelli S, Cozzi E, et al. La cardioversione farmacologica d\u00e9lia fibrillazione atriale: Tre metodi a confronto.Clin Ter 1987;122:93\u201398.","journal-title":"Clin Ter"},{"key":"BF03029730_CR132","first-page":"477","volume":"100","author":"B Allaria","year":"1982","unstructured":"Allaria B. Trattamento della fibrillazione atriale di recente insorgenza mediante associazione fra chinidina e amiodarone.Clin Ter 1982;100:477\u2013484.","journal-title":"Clin Ter"},{"key":"BF03029730_CR133","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.CIR.31.5.670","volume":"31","author":"JJ Morris","year":"1965","unstructured":"Morris JJ Jr., Entman M, North WC, et al. The changes in cardiac output with reversion of atrial fibrillation to sinus rhythm.Circulation 1965;31:670\u2013678.","journal-title":"Circulation"},{"key":"BF03029730_CR134","first-page":"274","volume-title":"Atrial fibrillation","author":"RWF Campbell","year":"1982","unstructured":"Campbell RWF. Drug prophylaxis of atrial fibrillation. In: Kulbertus HE, Olsson SB, Schlepper M, eds.Atrial fibrillation. Molndal, Sweden: AB Hassle, 1982:274\u2013281."},{"key":"BF03029730_CR135","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.82.4.1106","volume":"82","author":"SE Coplen","year":"1990","unstructured":"Coplen SE, Antman EM, Berlin et al. Efficacy and safety of quinidine therapy for maintenance sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation 1990;82:1106\u20131116.","journal-title":"Circulation"},{"key":"BF03029730_CR136","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/hrt.30.1.84","volume":"30","author":"JI Hall","year":"1968","unstructured":"Hall JI, Wood DR. Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine.Br Heart J 1968;30:84\u201389.","journal-title":"Br Heart J"},{"key":"BF03029730_CR137","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0002-9149(84)90260-1","volume":"54","author":"MT Flugelman","year":"1984","unstructured":"Flugelman MT, Hasin Y, Katznelson N, et al. Restoration and maintenance of sinus rhythm after mitral valve surgery for mitral stenosis.Am J Cardiol 1984;54:617\u2013619.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR138","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0002-9149(89)90079-9","volume":"63","author":"MA Brodsky","year":"1989","unstructured":"Brodsky MA, Allen JB, Capparelli EV, et al. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation.Am J Cardiol 1989;63:1065\u20131068.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR139","first-page":"13","volume-title":"Atrial fibrillation","author":"TN James","year":"1982","unstructured":"James TN. Diversity of histopathologic correlates of atrial fibrillation. In: Kulbertus HE, Olsson SB, Schlepper M, eds.Atrial fibrillation. Molndal, Sweden: AB Hassle, 1982:13\u201330."},{"key":"BF03029730_CR140","doi-asserted-by":"crossref","first-page":"l","DOI":"10.1016\/0146-2806(80)90020-1","volume":"5","author":"DC Morris","year":"1980","unstructured":"Morris DC, Hurst JW. Atrial fibrillation.Curr Probl Cardiol 1980;5:l-51.","journal-title":"Curr Probl Cardiol"},{"key":"BF03029730_CR141","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/hrt.37.5.486","volume":"37","author":"J Sodermark","year":"1975","unstructured":"Sodermark J, Sjogren A, Edhag O, et al. Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter.Br Heart J 1975;37:486\u2013492.","journal-title":"Br Heart J"},{"key":"BF03029730_CR142","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cpt1974156551","volume":"15","author":"G Hartel","year":"1974","unstructured":"Hartel G, Louija A, Konttinen A. Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion.Clin Probl Ther 1974;15:551\u2013555.","journal-title":"Clin Probl Ther"},{"key":"BF03029730_CR143","first-page":"367","volume":"65","author":"EA Lloyd","year":"1984","unstructured":"Lloyd EA, Gersch BJ, Forman R. The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A double blind study comparing quinidine, disopyramide and placebo.South Afr Med J 1984;65:367\u2013378.","journal-title":"South Afr Med J"},{"key":"BF03029730_CR144","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/hrt.63.4.225","volume":"63","author":"JM Rawles","year":"1990","unstructured":"Rawles JM, Metcalfe M,. Jennings K. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: The effect of digoxin.Br Heart J 1990;63: 225\u2013227.","journal-title":"Br Heart J"},{"key":"BF03029730_CR145","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0002-9149(87)90307-9","volume":"60","author":"MA Brodsky","year":"1987","unstructured":"Brodsky MA, Allen BJ, Walker CJ, et al. Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium.Am J Cardiol 1987;60:572\u2013575.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR146","first-page":"1727","volume":"44","author":"J Riviere","year":"1974","unstructured":"Riviere J, Roger P, Dugravier F, et al. Hyperthyroidie et amiodarone.Nouv Press Med 1974;44:1727\u20131728.","journal-title":"Nouv Press Med"},{"key":"BF03029730_CR147","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0002-8703(83)90008-X","volume":"106","author":"B Singh","year":"1983","unstructured":"Singh B, Nademanee K. Amiodarone and thyroid function: Clinical implications during antiarrhythmic therapy.Am Heart J 1983;106:857\u2013868.","journal-title":"Am Heart J"},{"key":"BF03029730_CR148","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archopht.1981.03930010259007","volume":"99","author":"D D\u2019Amico","year":"1981","unstructured":"D\u2019Amico D, Kenyou K, Ruskin J. Amiodarone keratopathy. Drug induced lipid storage disease.Arch Opthalm 1981;99:257\u2013261.","journal-title":"Arch Opthalm"},{"key":"BF03029730_CR149","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/0002-8703(83)90015-7","volume":"106","author":"L Rakita","year":"1983","unstructured":"Rakita L, Sobol S, Mostow N, Brobel T. Amiodarone pulmonary toxicity.Am Heart J 1983;106:906\u2013914.","journal-title":"Am Heart J"},{"key":"BF03029730_CR150","first-page":"497","volume":"32","author":"R Bolognesi","year":"1982","unstructured":"Bolognesi R, Vasini P, Cimicchi MC, et al. Polmonite da amiodarone. Descrizione di un caso e revisione della letteratura.Cadiologia 1982;32:497\u2013502.","journal-title":"Cadiologia"},{"key":"BF03029730_CR151","first-page":"131","volume":"98","author":"J Wanet","year":"1971","unstructured":"Wanet J, Achten G, Barchweitz G, et al. Amiodarone et depots cutan\u00e9es. Etude clinique et histologique.Ann Dermatol Syphil 1971;98:131\u2013141.","journal-title":"Ann Dermatol Syphil"},{"key":"BF03029730_CR152","first-page":"203","volume-title":"Amiodarone","author":"L Harris","year":"1986","unstructured":"Harris L. Unwanted effects. In: Haris L, Roncucci R, eds.Amiodarone. Paris: MEDSI, 1986:203\u2013269."},{"issue":"I","key":"BF03029730_CR153","first-page":"52","volume":"9","author":"IV Gelder","year":"1988","unstructured":"Gelder IV, Crijns H, Gilst WV, Lie KI. Efficacy of flecainide to maintain sinus rhythm after cardioversion of atrial fibrillation and flutter. In: Abstracts of Xth Congress of the European Society of Cardiology.Eur Heart J 1988; 9(Suppl. I):52.","journal-title":"Eur Heart J"},{"issue":"I","key":"BF03029730_CR154","first-page":"52","volume":"9","author":"K Rasmussen","year":"1988","unstructured":"Rasmussen K, Andersen A, Abrahamsen AM, et al. Flecainide versus disopyramide in maintaining sinus rhythm following conversion of chronic atrial fibrillation. In: Abstracts of Xth Congress of the European Society of Cardiology.Eur Heart J 1988;9(Suppl. I):52.","journal-title":"Eur Heart J"},{"key":"BF03029730_CR155","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.80.6.1557","volume":"80","author":"JL Anderson","year":"1989","unstructured":"Anderson JL, Gilbert EM, Alpert BL, et al. and the Flecainide Supraventricular Tachycardia Study Group. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy.Circulation 1989;80:1557\u20131570.","journal-title":"Circulation"},{"key":"BF03029730_CR156","first-page":"559","volume":"74","author":"M Epstein","year":"1988","unstructured":"Epstein M, Jardine RM, Obel IWP. Flecainide acetate in the treatment of resistant supraventricular arrhythmias.S Afr Med J 1988;74:559\u2013562.","journal-title":"S Afr Med J"},{"key":"BF03029730_CR157","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1001\/jama.1989.03430210079035","volume":"262","author":"LK Hine","year":"1989","unstructured":"Hine LK, Laird NM, Hewitt P, Chalmers TC. Metaanalysis of empirical long-term antiarrhythmic therapy after myocardial infarction.JAMA 1989;262:3037\u20133040.","journal-title":"JAMA"},{"key":"BF03029730_CR158","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-9149(90)90856-V","volume":"66","author":"GK Feld","year":"1990","unstructured":"Feld GK, Chen PS, Nicod P, et al. Possible atrial proarrhythmic effects of Class I C antiarrhythmic drugs.Am J Cardiol 1990;66:378\u2013383.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR159","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/0003-4819-111-2-107","volume":"11","author":"RH Falk","year":"1989","unstructured":"Falk RH. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.Ann Intern Med 1989;11:107\u2013111.","journal-title":"Ann Intern Med"},{"key":"BF03029730_CR160","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0735-1097(90)90649-A","volume":"15","author":"EM Antman","year":"1990","unstructured":"Antman EM, Beamer AD, Cantillon C, et al. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: A staged care approach with new antiarrhythmic drugs.J Am Coll Cardiol 1990;15:698\u2013707.","journal-title":"J Am Coll Cardiol"},{"key":"BF03029730_CR161","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0002-9149(89)90049-0","volume":"63","author":"SJ Connolly","year":"1989","unstructured":"Connolly SJ, Hoffert DL. Usefulness of propafenone for recurrent paroxysmal atrial fibrillation.Am J Cardiol 1989;63:817\u2013819.","journal-title":"Am J Cardiol"},{"key":"BF03029730_CR162","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0002-9149(89)91091-6","volume":"63","author":"JG Porterfield","year":"1989","unstructured":"Porterfield JG, Porterfield LM. Therapeutic efficacy and safety of oral propafenone for atrial fibrillation.Am J Cardiol 1989;63:114\u2013116.","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03029730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03029730\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03029730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:40:00Z","timestamp":1738921200000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03029730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,6]]},"references-count":162,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1991,6]]}},"alternative-id":["BF03029730"],"URL":"https:\/\/doi.org\/10.1007\/bf03029730","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[1991,6]]}}}